A spiropyran-coumarin platform: an environment sensitive photoresponsive drug delivery system for efficient cancer

Shrabani Barman1, Joyjyoti Das, Sandipan Biswas

  • 1Department of Chemistry, Indian Institute of Technology, Kharagpur 721302, West Bengal, India. ndpradeep@chem.iitkgp.ernet.in.

Insights

This study introduces a novel photoresponsive drug delivery system that combines spiropyran and coumarin. This system enhances anti-cancer drug delivery by responding to both tumor pH and external light, improving targeting and reducing toxicity.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Pharmacology

Background:

  • Current anticancer agents suffer from severe host toxicity due to nonspecific biodistribution.
  • There is a need for efficient and targeted anti-cancer drug delivery systems.

Purpose of the Study:

  • To design and develop a single-component, photoresponsive drug delivery system for enhanced anti-cancer therapy.
  • To create a system that synchronizes internal (pH) and external (light) triggers for controlled drug release.

Main Methods:

  • Fusion of spiropyran and coumarin platforms into a single component system (SP-Cou-Cbl).
  • Utilized the lower pH of cancer tissue to trigger spiropyran ring-opening and coumarin fluorescence activation.
  • Employed external light to control the release of an anti-tumor drug.

Main Results:

  • The SP-Cou-Cbl system demonstrated a distinct color change and fluorescence activation in response to pH.
  • External light successfully controlled the release of the anti-tumor drug.
  • The system exhibited high fluorescence and promising biocompatibility.

Conclusions:

  • The developed photoresponsive system offers a dual-control mechanism for targeted anti-cancer drug delivery.
  • The SP-Cou-Cbl system is suitable for cell imaging and in vitro studies due to its fluorescence and biocompatibility.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Drug Delivery: Overview01:16

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
652